Trade Bristol Myers ^BMY

Bristol-Myers Weighs RNA Expansion Against Sprycel Generic Pressures

Bristol-Myers Squibb (BMY) Poised for Upside With Registrational Data Ahead

Bristol Myers Squibb Company $BMY Shares Sold by Pettee Investors Inc.

Peterson Wealth Services Buys 41,762 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Principal Financial Group Inc.

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Regeneron (REGN) | Markets Insider

TD Waterhouse Canada Inc. Lowers Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol-Myers Squibb Company (BMY): A Bull Case Theory

TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding Immuno-Oncology Pipeline | DelveInsight

Best Pharmaceutical Stocks To Watch Today - February 1st - Markets Daily

Lupin launches generic cancer drug in U.S.

Convergence Investment Partners LLC Raises Stake in Bristol Myers Squibb Company $BMY

Mutual Advisors LLC Increases Holdings in Bristol Myers Squibb Company $BMY

Piper Sandler Raises Bristol Myers (BMY) PT to $66 Citing Pipeline Visibility

Here are the 7 big things we're focused on in the stock market this week

Top Pharmaceutical Stocks To Add to Your Watchlist - January 31st - Markets Daily

Y Intercept Hong Kong Ltd Sells 170,707 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Acquired by Mediolanum International Funds Ltd

Bristol-Myers Squibb Cancer And AI Deals Put Valuation In Focus

Summit Global Investments Acquires New Position in Bristol Myers Squibb Company $BMY - Daily Political

Covalent inhibitor design confers activity against both GDP- and GTP-bound forms of KRAS G12C

Citi Raises Bristol-Myers (BMY) Target as Sector Outlook Improves into 2026

IgG4-Related Disease Market Size is Projected to grow at a CAGR of 34.60% by 2034, estimates DelveInsight

Bristol Myers Moves Supreme Court to Stop Zydus from Selling Biosimilar Cancer Drug - The Economic Times

Bristol Myers moves SC to stop Zydus from selling biosimilar cancer drug - The Economic Times

Ruffer LLP Invests $6.84 Million in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Stock Position Increased by Mirae Asset Global Investments Co. Ltd.

Truist Financial Corp Has $58.25 Million Stake in Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Company $BMY Position Trimmed by Truist Financial Corp

Bank of New York Mellon Corp Cuts Stake in Bristol Myers Squibb Company $BMY

AustralianSuper Pty Ltd Lowers Stock Holdings in Bristol Myers Squibb Company $BMY

Is Bristol Myers Squibb (BMY) Pricing Reflect Its Fundamentals After A Steady Share Performance

Bristol Myers Squibb (BMY) to Release Quarterly Earnings on Thursday

Bristol Myers Squibb (BMY), Microsoft (MSFT) Partner to Enhance Early Lung Cancer Detection Through AI

10 Best Blue-Chip Stocks to Buy for the Long Term | Morningstar

Cambiar Investors LLC Trims Stake in Bristol Myers Squibb Company $BMY - Markets Daily

Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial

Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trial

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial

Janux Therapeutics Partners With Bristol-Myers (BMY) on Solid Tumor Therapy

Phoenix Financial Ltd. Raises Stock Position in Bristol Myers Squibb Company $BMY

Vanguard Personalized Indexing Management LLC Reduces Stock Position in Bristol Myers Squibb Company $BMY

Mutual of America Capital Management LLC Lowers Position in Bristol Myers Squibb Company $BMY - Markets Daily

Syngene Presses Ahead With Capex And Capacity Build As Biologics Impact Weighs On Q3

Belpointe Asset Management LLC Purchases 30,833 Shares of Bristol Myers Squibb Company $BMY

Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade

RET Fusion Targeted Therapies Market Set for Robust Growth by 2034 Amid Precision Oncology Shift | DelveInsight

Patten & Patten Inc. TN Decreases Stock Holdings in Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Company $BMY Shares Sold by Patten & Patten Inc. TN - Stock Observer

Lbp Am Sa Cuts Stake in Bristol Myers Squibb Company $BMY - Daily Political

MBM Wealth Consultants LLC Takes Position in Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Company $BMY Shares Acquired by Sector Gamma AS - Markets Daily

Trek Financial LLC Invests $1.49 Million in Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Company $BMY Shares Sold by Quilter Plc

Resona Asset Management Co. Ltd. Sells 46,004 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

Resona Asset Management Co. Ltd. Lowers Stock Holdings in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Purchased by UniSuper Management Pty Ltd

Bristol Myers Squibb Company $BMY Shares Acquired by Mitsubishi UFJ Trust & Banking Corp

iA Global Asset Management Inc. Boosts Stake in Bristol Myers Squibb Company $BMY

Strs Ohio Decreases Holdings in Bristol Myers Squibb Company $BMY

Camzyos Trial Win and Microsoft AI Lung Program Might Change The Case For Investing In BMY

A Look At Bristol Myers Squibb (BMY) Valuation After New Microsoft AI Pact And Camzyos Trial Results

Teacher Retirement System of Texas Increases Position in Bristol Myers Squibb Company $BMY - Markets Daily

Zydus Lifesciences launches world's first nivolumab biosimilar in India, boosting cancer treatment affordability - The Economic Times

Syngene Intl looks to diversify revenue as single biologics programme weighs on performance

Teacher Retirement System of Texas Acquires 168,780 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Did AI Lung Imaging And New HCM Data Just Shift Bristol Myers Squibb's (BMY) Investment Narrative?

Zydus Rolls Out Biosimilar of 'Nivolumab' Cancer Drug - The Economic Times

Microsoft Pushes Applied AI Deeper Into Retail And Healthcare Workflows

Want Decades of Passive Income? Buy This ETF and Hold It Forever

Q4 EPS Forecast for Bristol Myers Squibb Reduced by Analyst

Johnson & Johnson (NYSE:JNJ) Q4 2025 Earnings Call Transcript

Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug

Janux Enters Collaboration And Exclusive Worldwide License Agreement With Bristol Myers Squibb

Zydus launches Opdivo biosimilar in India at one-fourth price of reference brand

Assessing Bristol Myers Squibb (BMY) Valuation After New Microsoft Lung Cancer Detection Partnership

Janux's tumor-activated platform draws BMS in potential $850M deal | BioWorld

Bristol-Myers (BMY): UBS Turns Bullish as Biotech and Pharma Show Signs of a Recovery

Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer

Telangana Targets $25 Billion Life Sciences Investment Push

Leerink Bullish on Bristol-Myers Squibb Company (BMY) Amid Ample Pipeline Optionality in 2026

Zacks Research Has Negative Outlook for BMY Q1 Earnings - Markets Daily

Microsoft (NASDAQ:MSFT) Price Target Cut to $660.00 by Analysts at Citigroup - Stock Observer

Bristol Myers Squibb Company (NYSE:BMY) Receives $56.86 Average Price Target from Analysts - Stock Observer

Bristol Myers Squibb (NYSE:BMY) Trading Down 1.9% - Here's Why

Bernstein Keeps Their Hold Rating on Bristol-Myers Squibb (BMY) | Markets Insider

Bristol Myers Squibb (NYSE:BMY) Shares Down 1.9% - Should You Sell? - Stock Observer

Bristol-Myers Squibb (BMY) Upgraded to Buy by UBS, Noting a Skewed Risk/Reward Ratio for the Stock

Drug pricing, patent losses, deals: Novo Nordisk, Pfizer execs weigh in

Bristol Myers partners with Microsoft for AI-driven lung cancer detection

Bristol Myers Squibb Foundation Launches National Program t

2 Top Blue-Chip Stocks to Buy and Hold in 2026 | Morningstar

Scotiabank Notes Bristol-Myers Squibb Company (BMY) as Appealing Investment in 2026

Pimco's Triumph in 2025: A Bold Bond Strategy Pays Off

Fed Independence on the Line? Political Influence in 2026

US Holiday Shopping Season: Record Online Sales Amid Economic Vulnerabilities

US Economic Outlook 2026: A Roubini Analysis

Fed's Divergent Votes: A Sign of Policy Uncertainty?

Trading wisdom: how can I improve myself as a trader?

Can you trade CFDs on crypto: platform to trade cryptocurrency CFDs

EQV stock price today: Is EQV Ventures a good investment?

How to start investing in dividend ETFs: 7 Dividend ETFs to Watch

TSLQ ETF price forecast: How to track TSLQ ETF prices?

India's Silver Demand Surge: New Loan Framework Boosts Market

ADP Employment Data and the Fed's Policy Path: A Closer Look

Silver and Gold Market Analysis: A Look at the Post-Rally Correction

Starmer Defends Budget Amidst Misleading Claims: 'UK Back on Track'

UBS Analysis: Swiss National Bank Likely Didn't Intervene in FX Market in October

CME Outage Disrupts Global Markets, Sparks Trader Frustration

Gold & Silver Outlook: Fed Rate Cut Expectations & Uncertainty Loom

US-Russia-Ukraine Peace Plan: Deadlock Amidst Western Discord